Mechanisms leading to the bronchoprotective effects of N-Acetylcysteine in human bronchi stimulated by lipopolysaccharide

L. Calzetta (Rome, Italy), P. Rogliani (Rome, Italy), F. Facciolo (Rome, Italy), B. Rinaldi (Naples, Italy), M. Cazzola (Rome, Italy), M. Matera (Naples, Italy)

Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Calzetta (Rome, Italy), P. Rogliani (Rome, Italy), F. Facciolo (Rome, Italy), B. Rinaldi (Naples, Italy), M. Cazzola (Rome, Italy), M. Matera (Naples, Italy). Mechanisms leading to the bronchoprotective effects of N-Acetylcysteine in human bronchi stimulated by lipopolysaccharide. 5253

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Anti-inflammatory profile of N-acetylcysteine in human bronchi stimulated with lipopolysaccharide
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016


Concomitant exposure to nicotine and endotoxin in vitro induces murine airway hyperreactivity possibly via nicotine-induced upregulation of toll-like receptors
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011


Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


N-Acetylcysteine protects human bronchi via inhibiting neurokinin A
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017

The role of isoprenylation in lipopolysaccharide (LPS)-induced human airway hyperresponsiveness
Source: Annual Congress 2010 - Models of airways disease
Year: 2010


Tiotropium inhibits acetylcholine-induced generation of proinflammatory microparticles by human pulmonary epithelial cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


Inhaled cationic salts modulate macrophage function to reduce inflammation during LPS induced lung injury
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

Inhibitory effect of statins on fibrogenic mediator production from lung cells
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003

Inhaled CCR1 antagonist AZD4818 reduces leucocyte influx in the rat lipopolysaccharide (LPS) lung inflammation model
Source: Annual Congress 2009 - Preclinical models in drug development
Year: 2009

Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


Anti-inflammatory effect of bosentan on endothelin-1- and TNF-α-induced GMCSF expression in human airways smooth muscle cells – role of MAPkinases ERK-1,-2
Source: Annual Congress 2007 - Inflammatory cell biology
Year: 2007


The effects of inhaled glucocorticoids on human neutrophil apoptosis
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001

Modulatory effects of immunosuppressives on IL-8 and GM-CSF expression in bronchial and alveolar epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 854s
Year: 2006

Resveratrol is superior to dexamethasone in suppressing cytokine release from human airway smooth muscle cells exposed to lipoteichoic acid in COPD
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013


Formoterol protects against platelet-activating factor-induced effects in asthma
Source: Eur Respir J 2004; 23: 71-75
Year: 2004



Effects of thromboxane A2 receptor antagonists on airway mucus overproduction induced by cigarette smoke and lipopolysaccharide
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009


Airway hyperresponsiveness to histamine induced by repetitive intraperitoneal injection of lipopolysacharide and the involvement of nitric oxide generation in guinea pigs
Source: Eur Respir J 2005; 26: Suppl. 49, 367s
Year: 2005

Protective effect of salbutamol on peripheral airway constriction induced by sputum induction in asthma patients
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017

Mechanisms of acetylcholine-induced release of proinflammatory extracellular vesicles by endothelial cells and inhibitory effects of tiotropium
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019